{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:30:06Z","timestamp":1792852206485,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109775","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T19:18:51Z","timestamp":1675711131000},"page":"109775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis"],"prefix":"10.1016","volume":"116","author":[{"given":"Xinyan","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2023.109775_b0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0015","first-page":"567","article-title":"Liver immunology, Comprehensive","volume":"3","author":"Bogdanos","year":"2013","journal-title":"Physiology"},{"key":"10.1016\/j.intimp.2023.109775_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2023.109775_b0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0039-3402516","article-title":"The Matrisome, Inflammation, and Liver Disease","volume":"40","author":"Dolin","year":"2020","journal-title":"Semin. Liver Dis."},{"issue":"6917","key":"10.1016\/j.intimp.2023.109775_b0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"issue":"23","key":"10.1016\/j.intimp.2023.109775_b0045","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.jacc.2016.09.945","article-title":"MicroRNAs in Cardiovascular Disease","volume":"68","author":"Barwari","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2023.109775_b0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-030-12668-1_7","article-title":"miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease","volume":"1134","author":"Suksangrat","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.intimp.2023.109775_b0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","article-title":"Exploring miRNA based approaches in cancer diagnostics and therapeutics","volume":"98","author":"Mishra","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109775_b0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/imm.12227","article-title":"Role of miR-155 in the regulation of lymphocyte immune function and disease","volume":"142","author":"Seddiki","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2023.109775_b0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2019.00463","article-title":"miR-155 in the Resolution of Atherosclerosis","volume":"10","author":"Bruen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109775_b0075","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1038\/srep10721","article-title":"Biodistribution and function of extracellular miRNA-155 in mice","volume":"5","author":"Bala","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1189\/jlb.3A0716-310R","article-title":"Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease","volume":"102","author":"Bala","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0085","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.109775_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.intimp.2023.109775_b0095","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00018-018-2753-8","article-title":"HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines","volume":"75","author":"Wang","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0100","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1159\/000447917","article-title":"Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"40","key":"10.1016\/j.intimp.2023.109775_b0105","doi-asserted-by":"crossref","first-page":"66051","DOI":"10.18632\/oncotarget.11800","article-title":"MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K\/SGK3\/\u03b2-catenin signaling pathways","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.intimp.2023.109775_b0110","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.tplants.2016.09.003","article-title":"miRNA Biogenesis: A Dynamic Pathway","volume":"21","author":"Achkar","year":"2016","journal-title":"Trends Plant Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","article-title":"Regulation of the MIR155 host gene in physiological and pathological processes","volume":"532","author":"Elton","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2023.109775_b0120","unstructured":"O. Y, F. XY, T. DM, P. SF, F. L, Expressions of miR-146a and miR-155 in different samples of chronic hepatitis B patients, J Cent South Univ (Med Sci) 44(08) (2019), 845\u2013849."},{"key":"10.1016\/j.intimp.2023.109775_b0125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fimmu.2019.00873","article-title":"Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients","volume":"10","author":"Mill\u00e1n","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.109775_b0130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/hepr.12424","article-title":"Clinical significance of intragraft miR-122 and -155 expression after liver transplantation","volume":"45","author":"Asaoka","year":"2015","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/105221616X693594","article-title":"Differential Expression of MicroRNAs in Hepatitis C Virus-Mediated Liver Disease Between African Americans and Caucasians: Implications for Racial Health Disparities","volume":"17","author":"Devhare","year":"2017","journal-title":"Gene Expr."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/br.2014.373","article-title":"Expression signature of microRNA-155 in hepatitis C virus genotype 4 infection","volume":"3","author":"Riad","year":"2015","journal-title":"Biomedical reports"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00432-011-1076-z","article-title":"Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation","volume":"138","author":"Han","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0150","doi-asserted-by":"crossref","first-page":"e36005","DOI":"10.5812\/hepatmon.36005","article-title":"How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study","volume":"16","author":"Poortahmasebi","year":"2016","journal-title":"Hepat. Mon."},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0155","first-page":"3381","article-title":"miR-155, miR-96 and miR-99a as potential diagnostic and prognostic tools for the clinical management of hepatocellular carcinoma","volume":"18","author":"Ning","year":"2019","journal-title":"Oncol. Lett."},{"issue":"37","key":"10.1016\/j.intimp.2023.109775_b0160","doi-asserted-by":"crossref","first-page":"60303","DOI":"10.18632\/oncotarget.11206","article-title":"MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma","volume":"7","author":"Ji","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.intimp.2023.109775_b0165","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.pcl.2019.06.011","article-title":"Innate Immunity","volume":"66","author":"Kaur","year":"2019","journal-title":"Pediatr. Clin. North Am."},{"issue":"12","key":"10.1016\/j.intimp.2023.109775_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124441","article-title":"Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy","volume":"21","author":"Ginefra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0002-9610(66)90201-7","article-title":"Newer anatomy of the liver and its variant blood supply and collateral circulation","volume":"112","author":"Michels","year":"1966","journal-title":"Am. J. Surg."},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0180","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.molmed.2019.01.006","article-title":"Is Resolution the End of Inflammation?","volume":"25","author":"Feehan","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2023.109775_b0190","first-page":"608","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Requirement of bic\/microRNA-155 for normal immune function"},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/1354750X.2021.1874051","article-title":"Chronic exposure to ethanol alters the expression of miR-155, miR-122 and miR-217 in alcoholic liver disease in an adult zebrafish model","volume":"26","author":"Pasqualotto","year":"2021","journal-title":"Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/imr.12057","article-title":"miR-155: an ancient regulator of the immune system","volume":"253","author":"Vigorito","year":"2013","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.intimp.2023.109775_b0205","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0210","doi-asserted-by":"crossref","first-page":"e34483","DOI":"10.5812\/hepatmon.34483","article-title":"Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients","volume":"16","author":"Yu","year":"2016","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.intimp.2023.109775_b0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1479-5876-10-151","article-title":"Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection","volume":"10","author":"Bala","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2023.109775_b0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.fob.2012.07.005","article-title":"Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4","volume":"2","author":"El-Ekiaby","year":"2012","journal-title":"FEBS Open Bio"},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0225","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/cphy.c120026","article-title":"Kupffer cells in the liver","volume":"3","author":"Dixon","year":"2013","journal-title":"Compr. Physiol."},{"issue":"11","key":"10.1016\/j.intimp.2023.109775_b0230","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2020.08.014","article-title":"Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease","volume":"190","author":"Slevin","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0235","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109775_b0240","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/TP.0000000000001765","article-title":"MicroRNA-155 Deficiency in Kupffer Cells Ameliorates Liver Ischemia-Reperfusion Injury in Mice","volume":"101","author":"Li","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2023.109775_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109398","article-title":"Promoted inhibition of TLR4\/miR-155\/ NF(k)B p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide","volume":"336","author":"Ali","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.apsb.2020.07.004","article-title":"The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis","volume":"11","author":"Yan","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0260","doi-asserted-by":"crossref","first-page":"18303","DOI":"10.1038\/s41598-020-75358-1","article-title":"MiR-155\/GSK-3\u03b2 mediates anti-inflammatory effect of Chikusetsusaponin IVa by inhibiting NF-\u03baB signaling pathway in LPS-induced RAW264.7 cell","volume":"10","author":"Xin","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2023.109775_b0265","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13238-012-2075-9","article-title":"MCP-1-induced protein-1, an immune regulator","volume":"3","author":"Xu","year":"2012","journal-title":"Protein Cell"},{"key":"10.1016\/j.intimp.2023.109775_b0270","article-title":"MCPIP1 regulates ROR\u03b1 expression to protect against liver injury induced by lipopolysaccharide via modulation of miR-155","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0275","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jvh.12126","article-title":"MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver","volume":"21","author":"Jiang","year":"2014","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0280","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0042-6822(91)91019-D","article-title":"Transcriptional factor C\/EBP binds to and transactivates the enhancer element II of the hepatitis B virus","volume":"183","author":"L\u00f3pez-Cabrera","year":"1991","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.intimp.2023.109775_b0285","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/jvh.12390","article-title":"Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C\/EBP-\u03b2 in hepatocytes","volume":"22","author":"Sarkar","year":"2015","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.intimp.2023.109775_b0290","doi-asserted-by":"crossref","first-page":"1206737","DOI":"10.1155\/2018\/1206737","article-title":"Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy","volume":"2018","author":"Liu","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0295","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/cmi.2014.91","article-title":"NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma","volume":"12","author":"Sun","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109775_b0300","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3389\/fimmu.2017.01173","article-title":"Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B","volume":"8","author":"Ge","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109775_b0305","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/imm.12463","article-title":"MicroRNA-155 regulates interferon-\u03b3 production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection","volume":"145","author":"Cheng","year":"2015","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.intimp.2023.109775_b0310","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v22.i7.2294","article-title":"Role of Tim-3 in hepatitis B virus infection: An overview","volume":"22","author":"Liu","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0315","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.109775_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8(+) T Cell Exhaustion in Cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0325","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/TP.0000000000000061","article-title":"Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts","volume":"97","author":"Li","year":"2014","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0330","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/tri.12528","article-title":"MicroRNA-155 deficiency attenuates ischemia-reperfusion injury after liver transplantation in mice","volume":"28","author":"Tang","year":"2015","journal-title":"Transplant international : official journal of the European Society for Organ Transplantation"},{"issue":"12","key":"10.1016\/j.intimp.2023.109775_b0335","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1139\/cjpp-2018-0467","article-title":"Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg\/Th17 cell differentiation","volume":"96","author":"Xia","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"10127","key":"10.1016\/j.intimp.2023.109775_b0340","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.intimp.2023.109775_b0345","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/CBM-190555","article-title":"MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a","volume":"27","author":"Li","year":"2020","journal-title":"Cancer biomarkers : section A of Disease markers"},{"key":"10.1016\/j.intimp.2023.109775_b0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2018.02.026","article-title":"MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R","volume":"421","author":"Al-Haidari","year":"2018","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.intimp.2023.109775_b0360","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00018-016-2146-9","article-title":"Reactivation of telomerase in cancer","volume":"73","author":"Akincilar","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.109775_b0365","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.arcmed.2016.08.003","article-title":"Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma","volume":"47","author":"Ezzat","year":"2016","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.intimp.2023.109775_b0370","first-page":"1","article-title":"Cell-cycle regulation, WormBook : the online review of C","author":"van den Heuvel","year":"2005","journal-title":"elegans biology"},{"issue":"7","key":"10.1016\/j.intimp.2023.109775_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071414","article-title":"Histone Deacetylase Inhibitors as Anticancer Drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109775_b0380","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejmech.2019.01.069","article-title":"Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation","volume":"166","author":"Singh","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2023.109775_b0385","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.omto.2020.05.002","article-title":"miR-155 Accelerates the Growth of Human Liver Cancer Cells by Activating CDK2 via Targeting H3F3A","volume":"17","author":"Xin","year":"2020","journal-title":"Molecular therapy oncolytics"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0390","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2019.03.011","article-title":"Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation","volume":"74","author":"Laugesen","year":"2019","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0395","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.intimp.2023.109775_b0400","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","article-title":"Akt in cancer: Mediator and more","volume":"59","author":"Revathidevi","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0405","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3892\/ijo.2016.3465","article-title":"MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2","volume":"48","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2023.109775_b0410","doi-asserted-by":"crossref","first-page":"218","DOI":"10.12659\/MSMBR.918134","article-title":"Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN","volume":"25","author":"Sun","year":"2019","journal-title":"Med. Sci. Monit. Basic Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.109775_b0415","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cas.13177","article-title":"MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K\/Akt pathway","volume":"108","author":"Fu","year":"2017","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100688","article-title":"HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation","volume":"27","author":"Niu","year":"2022","journal-title":"Ann. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109775_b0425","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.4161\/cc.9.9.11595","volume":"9","author":"Davidson","year":"2010","journal-title":"The cell cycle and Wnt, Cell cycle (Georgetown, Tex.)"},{"key":"10.1016\/j.intimp.2023.109775_b0430","doi-asserted-by":"crossref","unstructured":"Y. Zhang, W. Wei, N. Cheng, K. Wang, B. Li, X. Jiang, S. Sun, Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling, Hepatology (Baltimore, Md.) 56(5) (2012) 1631-40.","DOI":"10.1002\/hep.25849"},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0435","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.aohep.2018.11.007","article-title":"Pegylated interferon-\u03b1 inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155","volume":"18","author":"Zhang","year":"2019","journal-title":"Ann. Hepatol."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2023.109775_b0440","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2019.07.011","article-title":"Novel role of the SRY-related high-mobility-group box D gene in cancer","volume":"67","author":"Liang","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109775_b0445","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/cncr.26566","article-title":"Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma","volume":"118","author":"Xie","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2023.109775_b0450","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3349\/ymj.2018.59.7.816","article-title":"XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p","volume":"59","author":"Lin","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.intimp.2023.109775_b0455","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.2741\/3483","article-title":"ZHX2 and ZHX3 repress cancer markers in normal hepatocytes","volume":"14","author":"Yamada","year":"2009","journal-title":"Front. Biosci. (Landmark edition)"},{"issue":"12","key":"10.1016\/j.intimp.2023.109775_b0460","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/ijc.31595","article-title":"HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation","volume":"143","author":"Song","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2023.109775_b0465","doi-asserted-by":"crossref","unstructured":"Q. Wang, G.T. Wang, W.H. Lu, MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1, Technology in cancer research & treatment 20 (2021) 1533033820957021.","DOI":"10.1177\/1533033820957021"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0470","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4149\/neo_2020_200106N17","article-title":"miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy","volume":"68","author":"Yu","year":"2021","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0475","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cels.2019.07.003","article-title":"Systems Biology of Cancer Metastasis","volume":"9","author":"Suhail","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.intimp.2023.109775_b0480","unstructured":"S. Dawood, L. Austin, M. Cristofanilli, Cancer stem cells: implications for cancer therapy, Oncology (Williston Park, N.Y.) 28(12) (2014) 1101-7, 1110."},{"key":"10.1016\/j.intimp.2023.109775_b0485","first-page":"1484","volume":"57","author":"Yamashita","year":"2013","journal-title":"Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma, Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2023.109775_b0490","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mc.22772","article-title":"NF-\u03baB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite","volume":"57","author":"Chen","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.intimp.2023.109775_b0495","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.febslet.2015.01.009","article-title":"MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal","volume":"589","author":"Liu","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.intimp.2023.109775_b0500","first-page":"829","volume":"62","author":"Ji","year":"2015","journal-title":"Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma, Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2023.109775_b0505","first-page":"1152","article-title":"Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL\/6 mice, Hepatology (Baltimore","volume":"50","author":"Wang","year":"2009","journal-title":"Md.)"},{"issue":"4","key":"10.1016\/j.intimp.2023.109775_b0510","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11684-018-0656-6","article-title":"Epithelial-to-mesenchymal transition in cancer: complexity and opportunities","volume":"12","author":"Zhang","year":"2018","journal-title":"Frontiers of medicine"},{"key":"10.1016\/j.intimp.2023.109775_b0515","article-title":"EMT, cancer stem cells and autophagy; The three main axes of metastasis","volume":"133","author":"Babaei","year":"2021","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0520","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.canlet.2015.01.030","article-title":"TGF-\u03b21 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes","volume":"359","author":"Liu","year":"2015","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0525","first-page":"2956","article-title":"MiR-155 up-regulated by TGF-\u03b2 promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro","volume":"9","author":"Li","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0530","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-018-0801-8","article-title":"Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3\/GSK-3\u03b2\/\u03b2-catenin signalling","volume":"37","author":"Liu","year":"2018","journal-title":"J. Experim. Clin. Cancer Res. CR"},{"issue":"5","key":"10.1016\/j.intimp.2023.109775_b0535","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2023.109775_b0540","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0545","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s10620-018-5380-1","article-title":"Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells","volume":"64","author":"Matsuura","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0550","first-page":"2274","article-title":"Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis, Hepatology (Baltimore","volume":"57","author":"Yan","year":"2013","journal-title":"Md.)"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0555","doi-asserted-by":"crossref","first-page":"19645","DOI":"10.1038\/s41598-019-56036-3","article-title":"Long noncoding RNA AURKAPS1 potentiates malignant hepatocellular carcinoma progression by regulating miR-142, miR-155 and miR-182","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0560","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7150\/ijbs.28422","article-title":"ING4 suppresses hepatocellular carcinoma via a NF-\u03baB\/miR-155\/FOXO3a signaling axis","volume":"15","author":"Qian","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0565","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0570","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: Regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2023.109775_b0575","doi-asserted-by":"crossref","unstructured":"Y. Yuhas, E. Berent, S. Ashkenazi, Effect of nitric oxide on microRNA-155 expression in human hepatic epithelial cells, Inflammation research : official journal of the European Histamine Research Society ... [et al.] 63(7) (2014) 591-6.","DOI":"10.1007\/s00011-014-0730-8"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0580","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2023.109775_b0585","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12329","article-title":"NEAT1: A novel cancer-related long non-coding RNA","volume":"50","author":"Yu","year":"2017","journal-title":"Cell Prolif."},{"key":"10.1016\/j.intimp.2023.109775_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2019.01.019","article-title":"Repression of lncRNA NEAT1 enhances the antitumor activity of CD8(+)T cells against hepatocellular carcinoma via regulating miR-155\/Tim-3","volume":"110","author":"Yan","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.intimp.2023.109775_b0595","first-page":"2214","article-title":"Biology and significance of alpha-fetoprotein in hepatocellular carcinoma, Liver international : official journal of the International Association for the Study of the","volume":"39","author":"Galle","year":"2019","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0600","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010090","article-title":"MiR-155: An Important Regulator of Neuroinflammation","volume":"23","author":"Zingale","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0605","doi-asserted-by":"crossref","DOI":"10.3390\/ncrna7030039","article-title":"Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications","volume":"7","author":"Jankauskas","year":"2021","journal-title":"Non-coding RNA"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0610","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgz183","article-title":"miR-155 as a novel clinical target for hematological malignancies","volume":"41","author":"Witten","year":"2020","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0615","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12885-019-6297-6","article-title":"The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis","volume":"19","author":"Shao","year":"2019","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0620","doi-asserted-by":"crossref","first-page":"e23025","DOI":"10.1002\/jbt.23025","article-title":"NF-\u03baB-upregulated miR-155-5p promotes hepatocyte mitochondrial dysfunction to accelerate the development of nonalcoholic fatty liver disease through downregulation of STC1","volume":"36","author":"Shen","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109775_b0625","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2023.109775_b0630","doi-asserted-by":"crossref","first-page":"241","DOI":"10.18632\/aging.103799","article-title":"In situ self-assembly of Au-antimiR-155 nanocomplexes mediates TLR3-dependent apoptosis in hepatocellular carcinoma cells","volume":"13","author":"Yin","year":"2020","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.intimp.2023.109775_b0635","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2013.03.020","article-title":"Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma","volume":"168","author":"Zhang","year":"2013","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.intimp.2023.109775_b0640","doi-asserted-by":"crossref","first-page":"25727","DOI":"10.1021\/acsami.1c04737","article-title":"Multifunctional Spiky Topological Nanocapsules for the Discrimination and Differential Inhibition of Inflammation and Cancer","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:21:45Z","timestamp":1719231705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692300098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":128,"alternative-id":["S156757692300098X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109775","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109775"}}